{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06067438",
            "orgStudyIdInfo": {
                "id": "STUDY00021572"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2023-03642",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trial Reporting Program)"
                },
                {
                    "id": "STUDY00021572",
                    "type": "OTHER",
                    "domain": "OHSU Knight Cancer Institute"
                }
            ],
            "organization": {
                "fullName": "OHSU Knight Cancer Institute",
                "class": "OTHER"
            },
            "briefTitle": "Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer",
            "officialTitle": "A Prospective, Randomized Controlled Trial Evaluating the Efficacy of Amiodarone in the Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Minimally Invasive Esophagectomy",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "amiodarone-for-the-prevention-of-atrial-fibrillation-after-minimally-invasive-esophagectomy-in-patients-with-esophageal-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07-25",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-08-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-08-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-06-01",
            "studyFirstSubmitQcDate": "2023-09-28",
            "studyFirstPostDateStruct": {
                "date": "2023-10-04",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-18",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Stephanie Wood",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "OHSU Knight Cancer Institute"
            },
            "leadSponsor": {
                "name": "OHSU Knight Cancer Institute",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This phase II trial studies how well amiodarone works in the prevention of atrial fibrillation (AF) after a minimally invasive esophagectomy (MIE) in patients with esophageal cancer. Atrial fibrillation (AF) is an irregular heart rhythm, usually associated with a rapid rate, that is caused by abnormal electrical activity within the atria. AF is the most common complication after MIE for esophageal cancer. There has never been a study of AF after MIE that has used unbiased assignment of patients to receive preventative amiodarone or not. Further, there is no standard recommendation or guideline for preventative medications, such as amiodarone, to decrease the risk of AF in patients having MIE performed for cancer. In fact, most medical centers in the United States and around the world do not give preventative amiodarone after esophagectomy. Giving amiodarone after MIE surgery may be able to reduce the risk of AF for patients with esophageal cancer.",
            "detailedDescription": "PRIMARY OBJECTIVE:\n\nI. To evaluate the effect of prophylactic amiodarone on the rate of atrial fibrillation (AF) in patients undergoing minimally invasive esophagectomy (MIE).\n\nSECONDARY OBJECTIVES:\n\nI. In each subobjective, below, evaluations of the effects of prophylactic amiodarone on the following will be made:\n\n* Ia. Postoperative (PostOp) rapid ventricular response;\n* Ib. Postop pulmonary complications;\n* Ic. Postop anastomotic leak;\n* Id. Intensive care unit (ICU) readmission;\n* Ie. ICU length of stay (LOS);\n* If. Hospital LOS;\n* Ig. 30-day readmission;\n* Ih. Inpatient mortality;\n* Ii. 30-day mortality;\n* Ij. Adverse events;\n* Ik. Time to AF;\n\nIl. Evaluating the association between therapeutic (or serum levels and the development of AF in the experimental group only.\n\nEXPLORATORY OBJECTIVE:\n\nI. To evaluate the effect of prophylactic amiodarone administration on hospital cost of care.\n\nOUTLINE: Patients are randomized to 1 of 2 arms.\n\nARM I: Patients receive amiodarone hydrochloride intravenously (IV) for 4 days and then via a feeding tube for 3 days on study.\n\nARM II: Patients receive placebo (normal saline) IV for 4 days on study.\n\nPatients are followed for 60 days following discharge from hospitalization after MIE."
        },
        "conditionsModule": {
            "conditions": [
                "Atrial Fibrillation",
                "Esophageal Carcinoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 90,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Arm I (amiodarone hydrochloride)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive amiodarone hydrochloride IV for 4 days and then via a feeding tube for 3 days on study.",
                    "interventionNames": [
                        "Drug: Amiodarone Hydrochloride"
                    ]
                },
                {
                    "label": "Arm II (normal saline)",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Patients receive normal saline IV for 4 days on study.",
                    "interventionNames": [
                        "Other: Saline"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Amiodarone Hydrochloride",
                    "description": "Given IV and via feeding tube",
                    "armGroupLabels": [
                        "Arm I (amiodarone hydrochloride)"
                    ],
                    "otherNames": [
                        "Cordarone",
                        "Nexterone"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Saline",
                    "description": "Given IV",
                    "armGroupLabels": [
                        "Arm II (normal saline)"
                    ],
                    "otherNames": [
                        "ISOTONIC SODIUM CHLORIDE SOLUTION",
                        "Sodium Chloride 0.9%"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Development of atrial fibrillation (AF), or completion of seven-day course of amiodarone",
                    "description": "Will be a binary variable (yes/no) and analyzed using a one-sided test of two proportions at an alpha level of 0.05.",
                    "timeFrame": "From initiation of amiodarone in the intensive care unit (ICU) to post-operative day (POD) 7, after last dose of enteral amiodarone"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Postoperative (PostOp) rapid ventricular response",
                    "description": "Will be a binary value (yes/no). Analysis: Binomial test; point estimate and 95% confidence interval (CI) of the difference between the two proportions.",
                    "timeFrame": "From initiation of amiodarone in the intensive care unit (ICU) to discharge (DC) from hospital."
                },
                {
                    "measure": "Postop pulmonary complications",
                    "description": "Including pneumonia, acute respiratory distress syndrome, acute pulmonary edema, and chylothorax. Analysis: Binomial test; point estimate and 95% CI of the difference between the two proportions.",
                    "timeFrame": "From initiation of amiodarone in the intensive care unit (ICU) to post-operative day (POD) 30"
                },
                {
                    "measure": "Anastomotic leak",
                    "description": "Will be a binary value (yes/no). Analysis: Binomial test; point estimate and 95% CI of the difference between the two proportions.",
                    "timeFrame": "From initiation of amiodarone in the intensive care unit (ICU) to post-operative day (POD) 30"
                },
                {
                    "measure": "ICU Readmission",
                    "description": "Will be a binary value (yes/no). Analysis: Binomial test; point estimate and 95% CI of the difference between the two proportions.",
                    "timeFrame": "From initiation of amiodarone in the intensive care unit (ICU) to post-operative day (POD) 30"
                },
                {
                    "measure": "ICU length of stay (LOS)",
                    "description": "Will be assessed in days. Analysis: Wilcoxon rank sum test",
                    "timeFrame": "From initiation of amiodarone in the intensive care unit (ICU) to time patient is moved out of ICU"
                },
                {
                    "measure": "Hospital LOS",
                    "description": "Will be assessed in days. Analysis: Wilcoxon rank sum test",
                    "timeFrame": "From initiation of amiodarone in the intensive care unit (ICU) to time of discharge from hospital"
                },
                {
                    "measure": "30 Day readmission rate",
                    "description": "Will be a binary value (yes/no). Analysis: Binomial test; point estimate and 95% CI of the difference between the two proportions.",
                    "timeFrame": "Day of discharge (DC) from hospital to 30 days after discharge"
                },
                {
                    "measure": "Inpatient morality",
                    "description": "Will be a binary value (yes/no). Analysis: Binomial test; point estimate and 95% CI of the difference between the two proportions.",
                    "timeFrame": "From initiation of amiodarone in the intensive care unit (ICU) to time of discharge from hospital"
                },
                {
                    "measure": "Incidence of mortality within 30 days of surgery",
                    "description": "Will be a binary value (yes/no). Analysis: Binomial test; point estimate and 95% CI of the difference between the two proportions.",
                    "timeFrame": "From initiation of amiodarone in the intensive care unit (ICU) to post-operative day (POD) 30"
                },
                {
                    "measure": "Incidence and type of adverse events",
                    "description": "Will be a binary value (yes/no). Analysis: Binomial test; point estimate and 95% CI of the difference between the two proportions.",
                    "timeFrame": "From initiation of amiodarone in the intensive care unit (ICU) to post-operative day (POD) 30"
                },
                {
                    "measure": "Time to AF",
                    "description": "Analysis: Log-rank test.",
                    "timeFrame": "From initiation of amiodarone in the intensive care unit (ICU) to post-operative day (POD) 7"
                },
                {
                    "measure": "Serum amiodarone level, classified as therapeutic or subtherapeutic",
                    "timeFrame": "Post-operative day (POD) 2 to post-operative day (POD) 3"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* All patients undergoing MIE will be evaluated for potential enrollment\n\n  * Indication of cancer, esophageal dysplasia or esophageal dysmotilities\n* Age \\> 18 years\n* Ability to understand and the willingness to sign a written informed consent document\n\nExclusion Criteria:\n\n* History of chronic or paroxysmal AF, or atrial flutter\n* Previous severe adverse reaction or contraindication to amiodarone (e.g., pulmonary toxicity/fibrosis, hepatotoxicity, thyroid dysfunction)\n* Current preoperative use of amiodarone, as baseline home medication\n* Development of AF intraoperatively\n* Pregnancy\n\n  * Negative pregnancy tests are required for participants of childbearing potential (PCBP) on Day of Surgery (DOS)\n* Breastfeeding/chest feeding\n* Aborted MIE operation\n* QTcB (Bazzett formula) \\> 500 for heart rate (HR) 60-100 within 30 days",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "overallOfficials": [
                {
                    "name": "Stephanie Wood",
                    "affiliation": "OHSU Knight Cancer Institute",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "OHSU Knight Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97239",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Stephanie Wood",
                            "role": "CONTACT",
                            "phone": "503-494-6900",
                            "email": "woodste@ohsu.edu"
                        },
                        {
                            "name": "Stephanie Wood",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000004938",
                    "term": "Esophageal Neoplasms"
                },
                {
                    "id": "D000001281",
                    "term": "Atrial Fibrillation"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001145",
                    "term": "Arrhythmias, Cardiac"
                },
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000006258",
                    "term": "Head and Neck Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000004935",
                    "term": "Esophageal Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M4586",
                    "name": "Atrial Fibrillation",
                    "asFound": "Atrial Fibrillation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8088",
                    "name": "Esophageal Neoplasms",
                    "asFound": "Esophageal Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4453",
                    "name": "Arrhythmias, Cardiac",
                    "relevance": "LOW"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M9348",
                    "name": "Head and Neck Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8085",
                    "name": "Esophageal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T2141",
                    "name": "Esophageal Cancer",
                    "asFound": "Esophageal Carcinoma",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000638",
                    "term": "Amiodarone"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000889",
                    "term": "Anti-Arrhythmia Agents"
                },
                {
                    "id": "D000014665",
                    "term": "Vasodilator Agents"
                },
                {
                    "id": "D000026902",
                    "term": "Potassium Channel Blockers"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000026941",
                    "term": "Sodium Channel Blockers"
                },
                {
                    "id": "D000065609",
                    "term": "Cytochrome P-450 CYP1A2 Inhibitors"
                },
                {
                    "id": "D000065607",
                    "term": "Cytochrome P-450 Enzyme Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000065688",
                    "term": "Cytochrome P-450 CYP2C9 Inhibitors"
                },
                {
                    "id": "D000065690",
                    "term": "Cytochrome P-450 CYP2D6 Inhibitors"
                },
                {
                    "id": "D000065692",
                    "term": "Cytochrome P-450 CYP3A Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M3976",
                    "name": "Amiodarone",
                    "asFound": "Uterine manipulator",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4213",
                    "name": "Anti-Arrhythmia Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M17412",
                    "name": "Vasodilator Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M23171",
                    "name": "Potassium Channel Blockers",
                    "relevance": "LOW"
                },
                {
                    "id": "M23177",
                    "name": "Sodium Channel Blockers",
                    "relevance": "LOW"
                },
                {
                    "id": "M30025",
                    "name": "Diuretics, Potassium Sparing",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M30537",
                    "name": "Cytochrome P-450 Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M30564",
                    "name": "Cytochrome P-450 CYP3A Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnArAg",
                    "name": "Anti-Arrhythmia Agents"
                },
                {
                    "abbrev": "ChanBlk",
                    "name": "Channel Blockers"
                },
                {
                    "abbrev": "VaDiAg",
                    "name": "Vasodilator Agents"
                }
            ]
        }
    },
    "hasResults": false
}